Pre-clinical studies have also shown that STAT3 inhibition can increase chemo and radiotherapy sensitization in HNSCC, particularly Nasopharyngeal Cancer (NPC) (43, 44). The gene discussed is STAT3; the disease is nasopharyngeal carcinoma.